Arkolith/Insider Trading/IBRX/Form 4

Selecky Christobel

DirectorImmunityBio, Inc. (IBRX) · full profile →Form 4 · filed Jul 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$871K
Net Open-Market Flow
-$871K
Transactions
12
7 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 30, 2026Option exercise(M)700$2.98$2K700
Jun 30, 2026Option exercise(M)300$2.99$8971K
Jun 30, 2026Sell(S)1K$9.00$9K0
Jun 29, 2026Sell(S)96K$9.01$862K0
Jun 29, 2026Option exercise(M)32K$2.98$96K32K
Jun 29, 2026Option exercise(M)34K$2.99$100K66K
Jun 29, 2026Option exercise(M)30K$2.84$85K96K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 30, 2026Option exercise(M)700—$035K
Jun 30, 2026Option exercise(M)300—$0124K
Jun 29, 2026Option exercise(M)32K—$036K
Jun 29, 2026Option exercise(M)34K—$0125K
Jun 29, 2026Option exercise(M)30K—$0133K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001849739-26-000011) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML